| OPINION |
|
| Year : 2014 | Volume
: 5
| Issue : 2 | Page : 55-59 |
|
|
Why are clinical trials necessary in India?
Subramani Poongothai, Ranjit Unnikrishnan, Jeyakumar Balasubramanian, Mohan Damodaran Nair, Viswanathan Mohan
Department of Clinical Trials, Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialties Centre, WHO Collaborating Centre for Non Communicable Diseases Prevention and Control, International Diabetes Federation Centre of Education, Chennai, India
Correspondence Address:
Viswanathan Mohan
Dr. Mohan's Diabetes Specialties Centre, WHO Collaborating Centre for Non Communicable Diseases Prevention and Control, International Diabetes Federation Centre of Education, Madras Diabetes Research Foundation, No. 6, Conran Smith Road, Gopalapuram, Chennai - 600 086
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2229-3485.128018
|
|
|
Clinical trials are emerging as an important activity in India as it is an essential component of the drug discovery and development program to which India is committed. The only robust way to evaluate a new medicine is by doing properly designed clinical trials. In addition to advancing science, clinical trials offer myriad benefits to the participants. The recent hue that created in India about clinical trials is probably an exaggeration of facts. However, these points to the need for ensuring proper compliance with the regulatory norms and proper training of concerned personnel in good clinical practice (GCP). This will ensure that India continues to reap the benefits of clinical trials and also become a world leader in this field. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
